⌘K

Seehra Jasbir

CHIEF EXECUTIVE OFFICER · 3 insider transactions on file

All transactions

Date	Ticker	Company	Type	Shares	Price	Value	Filing
2026-04-02	KROS	Keros Therapeutics, Inc.	Option exercise	55,000	$0.30	$16,500.00	filing
2026-02-19	KROS	Keros Therapeutics, Inc.	Sale	7,015	$16.17	$113,432.55	filing
2025-09-03	KROS	Keros Therapeutics, Inc.	Award	90,500	$0.00	$0.00	filing

Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.